Skip to main content

FDA Drug Recalls

Every FDA drug enforcement recall Public Health Trace has on record, republished from openFDA's official drug enforcement database. See Health Alerts for current, active recalls alongside outbreaks and advisories.

Drug recall information is sourced from the FDA's structured openFDA Enforcement Reports. Newly announced recalls may appear on FDA.gov before they become available in the structured dataset. See Methodology for how Public Health Trace imports and refreshes this data.

Filters
Recall details
Location
Date range
Clear filters

Showing 7,161–7,180 of 17,964 drug recalls

Drug Recall Terminated Historical recordClass II

Prednisolone Sodium Phosphate Oral Solution, 15 mg/5 mL, packaged in a 8 fl oz (237 mL) bottle, Rx only, Manufactured By Morton Grove Pharmaceuticals, Inc., Morton Grove, IL 60053. NDC 60432-212-08

by Morton Grove Pharmaceuticals, Inc.

Reason
Failed Impurities/Degradation Specifications - failed specs for Prednisolone Impurity 14
Recall initiated
September 23, 2019
Reported by FDA
October 16, 2019
Distribution
Nationwide USA and Puerto Rico

View recall →

Drug Recall Terminated Historical recordClass II

Sandoz Ranitidine Hydrochloride Capsules 300mg 30 Capsules Rx Only Manufactured by Sandoz Inc. Princeton, NJ 08540 Product of India NDC 0781-2865-31

by Sandoz, Inc

Reason
CGMP Deviations: Detection of a trace amount of an unexpected impurity, N-nitrosodimethylamine (NDMA).
Recall initiated
September 23, 2019
Reported by FDA
October 16, 2019
Distribution
U.S. Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Sandoz Ranitidine Hydrochloride Capsules 150mg 500 Capsules Rx Only Manufactured by Sandoz Inc. Princeton, NJ 08540 Product of India NDC 0781-2855-05

by Sandoz, Inc

Reason
CGMP Deviations: Detection of a trace amount of an unexpected impurity, N-nitrosodimethylamine (NDMA).
Recall initiated
September 23, 2019
Reported by FDA
October 16, 2019
Distribution
U.S. Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Sandoz Ranitidine Hydrochloride Capsules 150mg 60 Capsules Rx Only Manufactured by Sandoz Inc. Princeton, NJ Product of India NDC 0781-2855-60

by Sandoz, Inc

Reason
CGMP Deviations: Detection of a trace amount of an unexpected impurity, N-nitrosodimethylamine (NDMA).
Recall initiated
September 23, 2019
Reported by FDA
October 16, 2019
Distribution
U.S. Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Major Infants' Gas Relief Drops, Simethicone Oral Suspension USP, 1 FL OZ (30 mL) bottle, Distributed by: Major Pharmaceuticals 17177 N Laurel Park Drive, Suite 233 Livonia, MI 48152 USA. NDC 0904-5894-30

by GCP Laboratories Inc

Reason
Microbial Contamination of Non-Sterile Product.
Recall initiated
September 18, 2019
Reported by FDA
October 16, 2019
Distribution
Distributed in MI and further distributed Nationwide.

View recall →

Drug Recall Terminated Historical recordClass II

Phenylephrine Hydrochloride Ophthalmic Solution, USP, 2.5%, 15 mL bottle, Rx only, Mfd. by: Akorn, Inc., Lake Forest, IL 60045; NDC 17478-201-15.

by Akorn, Inc.

Reason
Lack of Assurance of Sterility: Out of specification results for container closure test which cannot guarantee the sterility of the product.
Recall initiated
September 20, 2019
Reported by FDA
October 9, 2019
Distribution
Nationwide in the USA and Puerto Rico

View recall →

Drug Recall Ongoing Historical recordClass II

Losartan Potassium/ Hydrochlorothiazide Tablets, USP 100mg/25mg, 90 tablets per bottle, Rx Only, Manufactured for: Torrent Pharma Inc., Basking Ridge, NJ 07920. NDC: 13668-118-90

by Torrent Pharma Inc.

Reason
CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level of 9.82 parts per million.
Recall initiated
September 19, 2019
Reported by FDA
October 9, 2019
Distribution
Nationwide USA and Puerto Rico

View recall →

Drug Recall Ongoing Historical recordClass II

Losartan Potassium /Hydrochlorothiazide Tablets, USP 50mg/12.5mg, 90 tablets per bottle, Rx Only, Manufactured for: Torrent Pharma Inc., Basking Ridge, NJ 07920. NDC: 13668-116-90

by Torrent Pharma Inc.

Reason
CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level of 9.82 parts per million.
Recall initiated
September 19, 2019
Reported by FDA
October 9, 2019
Distribution
Nationwide USA and Puerto Rico

View recall →

Drug Recall Ongoing Historical recordClass II

Losartan Potassium Tablets, USP 100 mg, [90 or 1000] tablets per bottle, Rx Only, Manufactured for: Torrent Pharma Inc., Basking Ridge, NJ 07920. NDC 90 tablets: 13668-115-90; NDC 1000 tablets: 13668-115-10

by Torrent Pharma Inc.

Reason
CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level of 9.82 parts per million.
Recall initiated
September 19, 2019
Reported by FDA
October 9, 2019
Distribution
Nationwide USA and Puerto Rico

View recall →

Drug Recall Ongoing Historical recordClass II

Losartan Potassium Tablets, USP 50mg, 1000 tablets per bottle, Rx Only, Manufactured for: Torrent Pharma Inc., Basking Ridge, NJ 07920. NDC: 13668-409-10

by Torrent Pharma Inc.

Reason
CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level of 9.82 parts per million.
Recall initiated
September 19, 2019
Reported by FDA
October 9, 2019
Distribution
Nationwide USA and Puerto Rico

View recall →

Drug Recall Terminated Historical recordClass II

Vivitrol (naltrexone for extended-release injectable suspension) 380 mg/vial. Each Carton Contains: 1) One vial of 380 mg of Vivitrol, 2) One vial containing 4 mL of diluent, 3) One 5-mL prepackaged syringe, 4) One 20-gauge 1-inch needle, 5) Two 20-gauge 1.5-inch safety needles, 6) Two 20-gauge 2-inch safety needles. Rx Only. Manufactured and marketed by: Alkermes, Inc. Kit NDC: 65757-300-01

by Alkermes, Inc.

Reason
Labeling: Not Elsewhere Classified. Drug product kit recalled due to 1 inch needles being placed in the 1 1/2 inch needle cardboard sleeve labelled as administration needles. The product vial is not impacted.
Recall initiated
September 26, 2019
Reported by FDA
October 9, 2019
Distribution
Nationwide USA and Canada

View recall →

Drug Recall Terminated Historical recordClass II

Isoproterenol HCL (PF) in D5W, 200 mcg / 50 mL (4 mcg/mL), 50 mL IV Bag, Single Dose Only, Contains Sulfites, For Slow IV use, Rx Only, KRS Global Biotechnology 791 Park of Commerce Blvd, Boca Raton, FL 33487. NDC 3321677610

by KRS Global Biotechnology, Inc

Reason
Lack of Assurance of Sterility
Recall initiated
September 12, 2019
Reported by FDA
October 9, 2019
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

L-Asparaginase Lyophilized, 10,000 International Units/Vial, For IV / IM / SC Use, Rx Only, KRS Global Biotechnology 791 Park of Commerce Blvd, Boca Raton, FL 33487. NDC 3321674499

by KRS Global Biotechnology, Inc

Reason
Lack of Assurance of Sterility
Recall initiated
September 12, 2019
Reported by FDA
October 9, 2019
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Cyclopentolate HCl 1% (10 mg/mL) / Phenylephrine HCl 10% (100 mg/mL) / Tropicamide 1% (10 mg/mL) / Ketorolac Tromethamine 0.5% (5 mg/mL), Sterile Ophthalmic Topical Solution, 5 mL Fill in a 7 mL Droptainer,Rx Only, KRS Global Biotechnology 791 Park of Commerce Blvd, Boca Raton, FL 33487. NDC 3321676223

by KRS Global Biotechnology, Inc

Reason
Lack of Assurance of Sterility
Recall initiated
September 12, 2019
Reported by FDA
October 9, 2019
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Vitamin B1/B2/B3/B6/HYDROXOCOBALAMIN 66/1.33/66/66/0.66 mg/mL (PF), For IV Use, 3 mL fill in a 5 mL Single Dose Vial, Rx Only, KRS Global Biotechnology 791 Park of Commerce Blvd, Boca Raton, FL 33487. NDC 3321678335

by KRS Global Biotechnology, Inc

Reason
Lack of Assurance of Sterility
Recall initiated
September 12, 2019
Reported by FDA
October 9, 2019
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Vitamin 9A/B Lyophilized, Vial For IM Use, Rx Only, KRS Global Biotechnology 791 Park of Commerce Blvd, Boca Raton, FL 33487. NDC 3321678339

by KRS Global Biotechnology, Inc

Reason
Lack of Assurance of Sterility
Recall initiated
September 12, 2019
Reported by FDA
October 9, 2019
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Vitamin 9 Lyophilized, Vial For IM Use, Rx Only, KRS Global Biotechnology 791 Park of Commerce Blvd, Boca Raton, FL 33487. NDC 3321674147

by KRS Global Biotechnology, Inc

Reason
Lack of Assurance of Sterility
Recall initiated
September 12, 2019
Reported by FDA
October 9, 2019
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Vitamin 5 B, 30 mL Vial For IM Use, Rx Only, KRS Global Biotechnology 791 Park of Commerce Blvd, Boca Raton, FL 33487. NDC 3321674253

by KRS Global Biotechnology, Inc

Reason
Lack of Assurance of Sterility
Recall initiated
September 12, 2019
Reported by FDA
October 9, 2019
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Vitamin 10 D Lyophilized, Vial For IM/Slow IV Infusion Use, Rx Only, KRS Global Biotechnology 791 Park of Commerce Blvd, Boca Raton, FL 33487. NDC 3321678341

by KRS Global Biotechnology, Inc

Reason
Lack of Assurance of Sterility
Recall initiated
September 12, 2019
Reported by FDA
October 9, 2019
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Vitamin 10 B Lyophilized, Vial, For IM Use, Rx Only, KRS Global Biotechnology 791 Park of Commerce Blvd, Boca Raton, FL 33487. NDC3321678338

by KRS Global Biotechnology, Inc

Reason
Lack of Assurance of Sterility
Recall initiated
September 12, 2019
Reported by FDA
October 9, 2019
Distribution
Nationwide

View recall →

Data last updated:

This information is republished from FDA's Recall Enterprise System through openFDA. Public Health Trace does not verify or supplement it, is not affiliated with the FDA, and does not provide medical advice -- always follow the guidance of your pharmacist, physician, or the recalling company for any medication you take. Read the full medical disclaimer.